Nationwide Analysis of Resuscitative Endovascular Balloon Occlusion of the Aorta in Civilian Trauma
IMPORTANCE: The need for improved methods of hemorrhage control and resuscitation has resulted in a reappraisal of resuscitative endovascular balloon occlusion of the aorta (REBOA). However, there is a paucity of data regarding the use of REBOA on a multi-institutional level in the United States. OB...
Saved in:
Published in | JAMA surgery Vol. 154; no. 6; pp. 500 - 508 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Medical Association
01.06.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | IMPORTANCE: The need for improved methods of hemorrhage control and resuscitation has resulted in a reappraisal of resuscitative endovascular balloon occlusion of the aorta (REBOA). However, there is a paucity of data regarding the use of REBOA on a multi-institutional level in the United States. OBJECTIVE: To evaluate the outcomes in trauma patients after REBOA placement. DESIGN, SETTING, AND PARTICIPANTS: A case-control retrospective analysis was performed of the 2015-2016 American College of Surgeons Trauma Quality Improvement Program data set, a national multi-institutional database of trauma patients in the United States. A total of 593 818 adult trauma patients (aged ≥18 years) were analyzed and 420 patients were matched and included in the study; patients who were dead on arrival or were transferred from other facilities were excluded. Trauma patients who underwent REBOA placement in the ED were identified and matched with a similar cohort of patients (the no-REBOA group). Both groups were matched in a 1:2 ratio using propensity score matching for demographics, vital signs, mechanism of injury, injury severity score, head abbreviated injury scale score, each body region abbreviated injury scale score, pelvic fractures, lower extremity vascular injuries and fractures, and number and grades of intra-abdominal solid organ injuries. MAIN OUTCOMES AND MEASURES: Outcome measures were the rates of complications and mortality. RESULTS: Of 593 818 trauma patients, 420 patients (the REBOA group, 140 patients; 36 women and 104 men; mean [SD] age, 44 [20] years; the no-REBOA group, 280 patients; 77 women and 203 men; mean [SD] age, 43 [19] years) were matched and included in the analysis. Among the REBOA group, median injury severity score was 29 (interquartile range [IQR], 18-38) and 129 patients (92.1%) had a blunt mechanism of injury. There was no significant difference between groups in median 4-hour blood transfusion (REBOA: packed red blood cells, 6 U [IQR, 3-8 U]; platelets, 4 U [IQR, 3-9 U], and plasma, 3 U [IQR, 2-5 U]; and no-REBOA: packed red blood cells, 7 U [IQR, 3-9 U]; platelets, 4 U [IQR, 3-8 U], and plasma, 3 U [IQR, 2-6 U]) or 24-hour blood transfusion (REBOA: packed red blood cells, 9 U [IQR, 5-20 U]; platelets, 7 U [IQR, 3-13 U], and plasma, 9 U [IQR, 6-20 U]; and no-REBOA: packed red blood cells, 10 U [IQR, 4-21 U]; platelets, 8 U [IQR, 3-12 U], and plasma, 10 U [IQR, 7-20 U]), median hospital length of stay (REBOA, 8 days [IQR, 1-20 days]; and no-REBOA, 10 days [IQR, 5-22 days]), or median intensive care unit length of stay (REBOA, 5 days [IQR, 2-14 days]; and no-REBOA, 6 days [IQR, 3-15 days]). The mortality rate was higher in the REBOA group as compared with the no-REBOA group (50 [35.7%] vs 53 [18.9%]; P = .01). Patients who underwent REBOA placement were also more likely to develop acute kidney injury (15 [10.7%] vs 9 [3.2%]; P = .02) and more likely to undergo lower extremity amputation (5 [3.6%] vs 2 [0.7%]; P = .04). CONCLUSIONS AND RELEVANCE: Placement of REBOA in severely injured trauma patients was associated with a higher mortality rate compared with a similar cohort of patients with no placement of REBOA. Patients in the REBOA group also had higher rates of acute kidney injury and lower leg amputations. There is a need for a concerted effort to clearly define when and in which patient population REBOA has benefit. |
---|---|
AbstractList | ImportanceThe need for improved methods of hemorrhage control and resuscitation has resulted in a reappraisal of resuscitative endovascular balloon occlusion of the aorta (REBOA). However, there is a paucity of data regarding the use of REBOA on a multi-institutional level in the United States. ObjectiveTo evaluate the outcomes in trauma patients after REBOA placement. Design, Setting, and ParticipantsA case-control retrospective analysis was performed of the 2015-2016 American College of Surgeons Trauma Quality Improvement Program data set, a national multi-institutional database of trauma patients in the United States. A total of 593 818 adult trauma patients (aged ≥18 years) were analyzed and 420 patients were matched and included in the study; patients who were dead on arrival or were transferred from other facilities were excluded. Trauma patients who underwent REBOA placement in the ED were identified and matched with a similar cohort of patients (the no-REBOA group). Both groups were matched in a 1:2 ratio using propensity score matching for demographics, vital signs, mechanism of injury, injury severity score, head abbreviated injury scale score, each body region abbreviated injury scale score, pelvic fractures, lower extremity vascular injuries and fractures, and number and grades of intra-abdominal solid organ injuries. Main Outcomes and MeasuresOutcome measures were the rates of complications and mortality. ResultsOf 593 818 trauma patients, 420 patients (the REBOA group, 140 patients; 36 women and 104 men; mean [SD] age, 44 [20] years; the no-REBOA group, 280 patients; 77 women and 203 men; mean [SD] age, 43 [19] years) were matched and included in the analysis. Among the REBOA group, median injury severity score was 29 (interquartile range [IQR], 18-38) and 129 patients (92.1%) had a blunt mechanism of injury. There was no significant difference between groups in median 4-hour blood transfusion (REBOA: packed red blood cells, 6 U [IQR, 3-8 U]; platelets, 4 U [IQR, 3-9 U], and plasma, 3 U [IQR, 2-5 U]; and no-REBOA: packed red blood cells, 7 U [IQR, 3-9 U]; platelets, 4 U [IQR, 3-8 U], and plasma, 3 U [IQR, 2-6 U]) or 24-hour blood transfusion (REBOA: packed red blood cells, 9 U [IQR, 5-20 U]; platelets, 7 U [IQR, 3-13 U], and plasma, 9 U [IQR, 6-20 U]; and no-REBOA: packed red blood cells, 10 U [IQR, 4-21 U]; platelets, 8 U [IQR, 3-12 U], and plasma, 10 U [IQR, 7-20 U]), median hospital length of stay (REBOA, 8 days [IQR, 1-20 days]; and no-REBOA, 10 days [IQR, 5-22 days]), or median intensive care unit length of stay (REBOA, 5 days [IQR, 2-14 days]; and no-REBOA, 6 days [IQR, 3-15 days]). The mortality rate was higher in the REBOA group as compared with the no-REBOA group (50 [35.7%] vs 53 [18.9%]; P = .01). Patients who underwent REBOA placement were also more likely to develop acute kidney injury (15 [10.7%] vs 9 [3.2%]; P = .02) and more likely to undergo lower extremity amputation (5 [3.6%] vs 2 [0.7%]; P = .04). Conclusions and RelevancePlacement of REBOA in severely injured trauma patients was associated with a higher mortality rate compared with a similar cohort of patients with no placement of REBOA. Patients in the REBOA group also had higher rates of acute kidney injury and lower leg amputations. There is a need for a concerted effort to clearly define when and in which patient population REBOA has benefit. This case-control study uses the American College of Surgeons Trauma-Quality Improvement Program data set to evaluate the outcomes in trauma patients after placement of resuscitative endovascular balloon occlusion of the aorta. The need for improved methods of hemorrhage control and resuscitation has resulted in a reappraisal of resuscitative endovascular balloon occlusion of the aorta (REBOA). However, there is a paucity of data regarding the use of REBOA on a multi-institutional level in the United States. To evaluate the outcomes in trauma patients after REBOA placement. A case-control retrospective analysis was performed of the 2015-2016 American College of Surgeons Trauma Quality Improvement Program data set, a national multi-institutional database of trauma patients in the United States. A total of 593 818 adult trauma patients (aged ≥18 years) were analyzed and 420 patients were matched and included in the study; patients who were dead on arrival or were transferred from other facilities were excluded. Trauma patients who underwent REBOA placement in the ED were identified and matched with a similar cohort of patients (the no-REBOA group). Both groups were matched in a 1:2 ratio using propensity score matching for demographics, vital signs, mechanism of injury, injury severity score, head abbreviated injury scale score, each body region abbreviated injury scale score, pelvic fractures, lower extremity vascular injuries and fractures, and number and grades of intra-abdominal solid organ injuries. Outcome measures were the rates of complications and mortality. Of 593 818 trauma patients, 420 patients (the REBOA group, 140 patients; 36 women and 104 men; mean [SD] age, 44 [20] years; the no-REBOA group, 280 patients; 77 women and 203 men; mean [SD] age, 43 [19] years) were matched and included in the analysis. Among the REBOA group, median injury severity score was 29 (interquartile range [IQR], 18-38) and 129 patients (92.1%) had a blunt mechanism of injury. There was no significant difference between groups in median 4-hour blood transfusion (REBOA: packed red blood cells, 6 U [IQR, 3-8 U]; platelets, 4 U [IQR, 3-9 U], and plasma, 3 U [IQR, 2-5 U]; and no-REBOA: packed red blood cells, 7 U [IQR, 3-9 U]; platelets, 4 U [IQR, 3-8 U], and plasma, 3 U [IQR, 2-6 U]) or 24-hour blood transfusion (REBOA: packed red blood cells, 9 U [IQR, 5-20 U]; platelets, 7 U [IQR, 3-13 U], and plasma, 9 U [IQR, 6-20 U]; and no-REBOA: packed red blood cells, 10 U [IQR, 4-21 U]; platelets, 8 U [IQR, 3-12 U], and plasma, 10 U [IQR, 7-20 U]), median hospital length of stay (REBOA, 8 days [IQR, 1-20 days]; and no-REBOA, 10 days [IQR, 5-22 days]), or median intensive care unit length of stay (REBOA, 5 days [IQR, 2-14 days]; and no-REBOA, 6 days [IQR, 3-15 days]). The mortality rate was higher in the REBOA group as compared with the no-REBOA group (50 [35.7%] vs 53 [18.9%]; P = .01). Patients who underwent REBOA placement were also more likely to develop acute kidney injury (15 [10.7%] vs 9 [3.2%]; P = .02) and more likely to undergo lower extremity amputation (5 [3.6%] vs 2 [0.7%]; P = .04). Placement of REBOA in severely injured trauma patients was associated with a higher mortality rate compared with a similar cohort of patients with no placement of REBOA. Patients in the REBOA group also had higher rates of acute kidney injury and lower leg amputations. There is a need for a concerted effort to clearly define when and in which patient population REBOA has benefit. IMPORTANCE: The need for improved methods of hemorrhage control and resuscitation has resulted in a reappraisal of resuscitative endovascular balloon occlusion of the aorta (REBOA). However, there is a paucity of data regarding the use of REBOA on a multi-institutional level in the United States. OBJECTIVE: To evaluate the outcomes in trauma patients after REBOA placement. DESIGN, SETTING, AND PARTICIPANTS: A case-control retrospective analysis was performed of the 2015-2016 American College of Surgeons Trauma Quality Improvement Program data set, a national multi-institutional database of trauma patients in the United States. A total of 593 818 adult trauma patients (aged ≥18 years) were analyzed and 420 patients were matched and included in the study; patients who were dead on arrival or were transferred from other facilities were excluded. Trauma patients who underwent REBOA placement in the ED were identified and matched with a similar cohort of patients (the no-REBOA group). Both groups were matched in a 1:2 ratio using propensity score matching for demographics, vital signs, mechanism of injury, injury severity score, head abbreviated injury scale score, each body region abbreviated injury scale score, pelvic fractures, lower extremity vascular injuries and fractures, and number and grades of intra-abdominal solid organ injuries. MAIN OUTCOMES AND MEASURES: Outcome measures were the rates of complications and mortality. RESULTS: Of 593 818 trauma patients, 420 patients (the REBOA group, 140 patients; 36 women and 104 men; mean [SD] age, 44 [20] years; the no-REBOA group, 280 patients; 77 women and 203 men; mean [SD] age, 43 [19] years) were matched and included in the analysis. Among the REBOA group, median injury severity score was 29 (interquartile range [IQR], 18-38) and 129 patients (92.1%) had a blunt mechanism of injury. There was no significant difference between groups in median 4-hour blood transfusion (REBOA: packed red blood cells, 6 U [IQR, 3-8 U]; platelets, 4 U [IQR, 3-9 U], and plasma, 3 U [IQR, 2-5 U]; and no-REBOA: packed red blood cells, 7 U [IQR, 3-9 U]; platelets, 4 U [IQR, 3-8 U], and plasma, 3 U [IQR, 2-6 U]) or 24-hour blood transfusion (REBOA: packed red blood cells, 9 U [IQR, 5-20 U]; platelets, 7 U [IQR, 3-13 U], and plasma, 9 U [IQR, 6-20 U]; and no-REBOA: packed red blood cells, 10 U [IQR, 4-21 U]; platelets, 8 U [IQR, 3-12 U], and plasma, 10 U [IQR, 7-20 U]), median hospital length of stay (REBOA, 8 days [IQR, 1-20 days]; and no-REBOA, 10 days [IQR, 5-22 days]), or median intensive care unit length of stay (REBOA, 5 days [IQR, 2-14 days]; and no-REBOA, 6 days [IQR, 3-15 days]). The mortality rate was higher in the REBOA group as compared with the no-REBOA group (50 [35.7%] vs 53 [18.9%]; P = .01). Patients who underwent REBOA placement were also more likely to develop acute kidney injury (15 [10.7%] vs 9 [3.2%]; P = .02) and more likely to undergo lower extremity amputation (5 [3.6%] vs 2 [0.7%]; P = .04). CONCLUSIONS AND RELEVANCE: Placement of REBOA in severely injured trauma patients was associated with a higher mortality rate compared with a similar cohort of patients with no placement of REBOA. Patients in the REBOA group also had higher rates of acute kidney injury and lower leg amputations. There is a need for a concerted effort to clearly define when and in which patient population REBOA has benefit. |
Author | O’Keeffe, Terence Kulvatunyou, Narong Rhee, Peter Hamidi, Mohammad Sakran, Joseph V Zeeshan, Muhammad Joseph, Bellal Khan, Muhammad |
AuthorAffiliation | 2 Division of Acute Care Surgery, Department of Surgery, Johns Hopkins Hospital, Baltimore, Maryland 3 Division of Acute Care Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia 1 Division of Trauma, Critical Care, Burn, and Emergency Surgery, Department of Surgery, College of Medicine, University of Arizona, Tucson |
AuthorAffiliation_xml | – name: 2 Division of Acute Care Surgery, Department of Surgery, Johns Hopkins Hospital, Baltimore, Maryland – name: 3 Division of Acute Care Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia – name: 1 Division of Trauma, Critical Care, Burn, and Emergency Surgery, Department of Surgery, College of Medicine, University of Arizona, Tucson |
Author_xml | – sequence: 1 givenname: Bellal surname: Joseph fullname: Joseph, Bellal – sequence: 2 givenname: Muhammad surname: Zeeshan fullname: Zeeshan, Muhammad – sequence: 3 givenname: Joseph V surname: Sakran fullname: Sakran, Joseph V – sequence: 4 givenname: Mohammad surname: Hamidi fullname: Hamidi, Mohammad – sequence: 5 givenname: Narong surname: Kulvatunyou fullname: Kulvatunyou, Narong – sequence: 6 givenname: Muhammad surname: Khan fullname: Khan, Muhammad – sequence: 7 givenname: Terence surname: O’Keeffe fullname: O’Keeffe, Terence – sequence: 8 givenname: Peter surname: Rhee fullname: Rhee, Peter |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30892574$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkU1r3DAQhkVJaT6aP5BD0bGX3Y5ky5YuhXRJm0JooKRnMSvJiYIspZK9Jf--Mpss7Vw08H6M4DklRzFFR8gFgzUDYJ8eccQy5_s1B6bWAKp7Q0446-Sq4x0_OuyiPSbnpTxCHQnQNuodOW5AKi769oSYHzj5FP946-hlxPBcfKFpoD9dmYvxU1V3jl5Fm3ZYzBww0y8YQkqR3hoT5lLDi396qPmUJ6Q-0o3f-eAx0ruM84jvydsBQ3HnL-8Z-fX16m5zvbq5_fZ9c3mzQsHEtOq53TIDvQV01kiQ2KHbKhissg0fQDWSCdsZ2ZteKNlwO3AwgwBjrVLYNWfk8773ad6OtcLFKWPQT9mPmJ91Qq__V6J_0PdppzshWy6gFnx8Kcjp9-zKpEdfjAsBo0tz0ZypVkgh5XKL760mp1KyGw5nGOgFkH4FpBdAegFUQx_-_eAh8oqjGi72hpo9qLznkqmm-Qu_Y5sY |
CitedBy_id | crossref_primary_10_1016_j_jvssci_2023_100100 crossref_primary_10_1136_tsaco_2019_000376 crossref_primary_10_1007_s40137_021_00285_7 crossref_primary_10_5847_wjem_j_1920_8642_2023_085 crossref_primary_10_1097_SHK_0000000000001814 crossref_primary_10_1016_j_surg_2021_01_043 crossref_primary_10_1097_TA_0000000000003894 crossref_primary_10_1007_s00068_020_01370_9 crossref_primary_10_1016_j_injury_2019_04_024 crossref_primary_10_1016_j_jss_2020_06_042 crossref_primary_10_1007_s00268_022_06832_2 crossref_primary_10_1186_s40001_021_00594_8 crossref_primary_10_1002_emp2_12228 crossref_primary_10_2106_JBJS_22_00252 crossref_primary_10_1097_BOT_0000000000002191 crossref_primary_10_1001_jama_2024_0285 crossref_primary_10_1111_ans_15771 crossref_primary_10_1016_j_jcot_2024_102407 crossref_primary_10_1002_jja2_12732 crossref_primary_10_1016_j_amjsurg_2022_09_057 crossref_primary_10_1001_jama_2024_0291 crossref_primary_10_1001_jamasurg_2019_2744 crossref_primary_10_1001_jamasurg_2022_6393 crossref_primary_10_1001_jamasurg_2019_2749 crossref_primary_10_1097_TA_0000000000004238 crossref_primary_10_1111_ans_15548 crossref_primary_10_1097_TA_0000000000003544 crossref_primary_10_1097_TA_0000000000003265 crossref_primary_10_1001_jamasurg_2019_2741 crossref_primary_10_1007_s12055_022_01413_3 crossref_primary_10_3138_jmvfh_2021_0118 crossref_primary_10_1007_s00068_019_01257_4 crossref_primary_10_1186_s12957_024_03398_2 crossref_primary_10_24884_0042_4625_2021_180_1_111_117 crossref_primary_10_1097_TA_0000000000004080 crossref_primary_10_1136_tsaco_2021_000723 crossref_primary_10_1186_s12873_020_00322_1 crossref_primary_10_1136_jramc_2019_001231 crossref_primary_10_1038_s41598_024_59861_3 crossref_primary_10_1186_s13049_023_01142_5 crossref_primary_10_1001_jamasurg_2019_2735 crossref_primary_10_1097_BOT_0000000000002243 crossref_primary_10_1097_TA_0000000000002747 crossref_primary_10_1097_SHK_0000000000001513 crossref_primary_10_1097_TA_0000000000003438 crossref_primary_10_1016_j_amjsurg_2020_07_017 crossref_primary_10_1097_SHK_0000000000001514 crossref_primary_10_1001_jamasurg_2019_2738 crossref_primary_10_1097_SHK_0000000000001636 crossref_primary_10_1097_TA_0000000000003556 crossref_primary_10_1186_s13017_021_00386_9 crossref_primary_10_1136_tsaco_2023_001267 crossref_primary_10_1097_TA_0000000000003670 crossref_primary_10_1007_s00068_020_01561_4 crossref_primary_10_1016_j_amjsurg_2022_11_035 crossref_primary_10_1152_ajprenal_00323_2023 crossref_primary_10_1016_j_injury_2024_111387 crossref_primary_10_1136_tsaco_2020_000534 crossref_primary_10_1186_s13017_020_00337_w crossref_primary_10_1186_s13049_020_00757_2 crossref_primary_10_1007_s00113_021_01055_x crossref_primary_10_1111_1742_6723_13432 crossref_primary_10_1016_j_jvs_2024_03_020 crossref_primary_10_1016_j_sipas_2021_100039 crossref_primary_10_1177_0003134820964496 crossref_primary_10_1097_SHK_0000000000001500 crossref_primary_10_20408_jti_2022_0069 crossref_primary_10_1016_j_jss_2023_12_044 crossref_primary_10_1097_XCS_0000000000000182 crossref_primary_10_25100_cm_v51i4_4506 crossref_primary_10_1001_jama_2023_20850 crossref_primary_10_1097_TA_0000000000003962 crossref_primary_10_1097_TA_0000000000003960 crossref_primary_10_1186_s13017_024_00548_5 crossref_primary_10_1161_CIR_0000000000001106 crossref_primary_10_1136_tsaco_2023_001153 crossref_primary_10_1038_s41598_022_07694_3 crossref_primary_10_1097_SHK_0000000000001586 crossref_primary_10_1007_s00104_020_01180_0 crossref_primary_10_1007_s43678_021_00100_3 crossref_primary_10_1016_j_jemermed_2024_03_010 crossref_primary_10_1016_j_amjsurg_2022_03_056 crossref_primary_10_1097_SLA_0000000000004743 crossref_primary_10_1111_aas_14172 crossref_primary_10_1016_j_suc_2024_01_002 crossref_primary_10_1016_j_jemermed_2021_11_017 crossref_primary_10_1007_s00068_023_02309_6 crossref_primary_10_1186_s12873_024_01020_y crossref_primary_10_4103_ija_IJA_121_20 crossref_primary_10_1007_s00068_021_01815_9 crossref_primary_10_1016_j_suronc_2020_08_016 crossref_primary_10_1097_TA_0000000000003331 crossref_primary_10_1136_tsaco_2019_000335 crossref_primary_10_1177_0003134820972985 crossref_primary_10_1186_s13017_023_00484_w crossref_primary_10_1136_tsaco_2020_000635 crossref_primary_10_1016_j_jss_2022_06_007 crossref_primary_10_1097_XCS_0000000000000669 crossref_primary_10_1016_j_sopen_2022_03_002 crossref_primary_10_1016_j_emc_2022_09_011 crossref_primary_10_1038_s41598_024_59778_x crossref_primary_10_1016_j_anclin_2020_08_010 crossref_primary_10_1177_0003134820988813 crossref_primary_10_30944_20117582_2369 crossref_primary_10_1007_s40719_024_00271_1 crossref_primary_10_1111_aogs_14317 crossref_primary_10_5554_22562087_e973 crossref_primary_10_1016_j_injury_2022_01_024 crossref_primary_10_1097_TA_0000000000002773 crossref_primary_10_1016_j_injury_2021_12_015 crossref_primary_10_1016_j_injury_2020_06_003 crossref_primary_10_1093_milmed_usae305 crossref_primary_10_1097_SLA_0000000000004055 crossref_primary_10_17479_jacs_2024_14_1_16 crossref_primary_10_1016_j_jacc_2022_08_004 crossref_primary_10_1097_TA_0000000000003193 crossref_primary_10_1016_j_amjsurg_2024_115798 crossref_primary_10_1007_s00402_024_05447_7 crossref_primary_10_1111_1742_6723_13443 crossref_primary_10_1007_s00068_024_02512_z crossref_primary_10_3390_healthcare11121784 crossref_primary_10_3389_fvets_2019_00197 crossref_primary_10_1371_journal_pone_0246127 crossref_primary_10_1097_TA_0000000000003239 crossref_primary_10_1007_s00590_023_03516_y crossref_primary_10_1177_15385744211042491 crossref_primary_10_1016_j_injury_2023_111183 crossref_primary_10_25100_cm_v52i2_4808 crossref_primary_10_1016_j_matdes_2021_109718 crossref_primary_10_1097_XCS_0000000000000403 crossref_primary_10_1016_j_jvs_2020_12_107 crossref_primary_10_1136_bmjopen_2021_053743 crossref_primary_10_1097_XCS_0000000000000124 crossref_primary_10_1136_tsaco_2020_000617 crossref_primary_10_1038_s41598_021_99635_9 crossref_primary_10_1097_SLA_0000000000003627 crossref_primary_10_1007_s00068_022_01955_6 crossref_primary_10_1111_ans_15873 crossref_primary_10_1002_emp2_12241 crossref_primary_10_1007_s43678_020_00057_9 crossref_primary_10_1016_j_amjsurg_2021_10_033 crossref_primary_10_1016_j_jss_2023_11_049 crossref_primary_10_1097_MD_0000000000034748 crossref_primary_10_1097_TA_0000000000003405 crossref_primary_10_1016_j_yasu_2022_03_002 crossref_primary_10_1016_j_aan_2021_07_002 crossref_primary_10_1177_00031348231157810 crossref_primary_10_1007_s00068_020_01345_w crossref_primary_10_1590_0100_6991e_20192334 crossref_primary_10_1016_j_jss_2020_06_034 crossref_primary_10_1097_TA_0000000000003124 crossref_primary_10_1097_MCC_0000000000001106 crossref_primary_10_5507_bp_2024_006 crossref_primary_10_1097_TA_0000000000002790 crossref_primary_10_1007_s00101_022_01100_3 crossref_primary_10_1007_s40719_019_00173_7 crossref_primary_10_1016_j_jtcvs_2023_04_023 crossref_primary_10_1016_j_jpedsurg_2020_01_052 crossref_primary_10_3389_fmed_2022_888225 crossref_primary_10_1016_j_jpedsurg_2020_09_011 crossref_primary_10_1016_j_injury_2022_07_025 crossref_primary_10_1097_SHK_0000000000001817 crossref_primary_10_1097_XCS_0000000000000136 crossref_primary_10_1007_s43678_020_00007_5 crossref_primary_10_1186_s13017_020_00342_z |
Cites_doi | 10.1097/TA.0000000000001079 10.1001/jamasurg.2017.3549 10.1097/TA.0000000000001858 10.1097/TA.0b013e3182946746 10.1097/SLA.0000000000000600 10.1177/000313481808400650 10.1097/TA.0000000000001794 10.1016/j.jamcollsurg.2018.01.044 10.1136/tsaco-2017-000154 10.1097/MCC.0000000000000359 10.1097/TA.0000000000001661 10.1016/S1072-7515(98)00082-9 10.1097/SHK.0000000000000085 10.1097/TA.0000000000000578 10.1111/ajo.2004.44.issue-2 10.1016/S0196-0644(86)80945-3 10.1097/TA.0b013e318221a94a 10.1097/TA.0b013e31829e5416 |
ContentType | Journal Article |
Copyright | Copyright 2019 American Medical Association. All Rights Reserved. |
Copyright_xml | – notice: Copyright 2019 American Medical Association. All Rights Reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1001/jamasurg.2019.0096 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | Nationwide Analysis of Resuscitative Endovascular Balloon Occlusion of the Aorta in Civilian Trauma |
EISSN | 2168-6262 |
EndPage | 508 |
ExternalDocumentID | 10_1001_jamasurg_2019_0096 30892574 2728193 |
Genre | Multicenter Study Journal Article |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GroupedDBID | 0R~ 4.4 AAWTL ABBLC ABJNI ACDNT ACGFS ADBBV AENEX AHMBA ALMA_UNASSIGNED_HOLDINGS AMJDE ANMPU BRYMA C45 EBD EBS EJD EMOBN EX3 GX1 OB2 OBH OHH OVD PQQKQ RAJ SV3 TEORI WOW CGR CUY CVF ECM EIF H13 NPM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-a515t-72db1c07d0aedc808a6aeb90fd9d32f093815d6c87c759832df20cf50cdd99a63 |
ISSN | 2168-6254 |
IngestDate | Tue Sep 17 21:26:35 EDT 2024 Sat Aug 17 00:12:35 EDT 2024 Fri Dec 06 04:45:33 EST 2024 Tue Aug 27 13:49:52 EDT 2024 Fri Jul 05 02:03:51 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-a515t-72db1c07d0aedc808a6aeb90fd9d32f093815d6c87c759832df20cf50cdd99a63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://jamanetwork.com/journals/jamasurgery/articlepdf/2728193/jamasurgery_joseph_2019_oi_190005.pdf |
PMID | 30892574 |
PQID | 2194585886 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6584250 proquest_miscellaneous_2194585886 crossref_primary_10_1001_jamasurg_2019_0096 pubmed_primary_30892574 ama_primary_2728193 |
PublicationCentury | 2000 |
PublicationDate | 2019-06-01 |
PublicationDateYYYYMMDD | 2019-06-01 |
PublicationDate_xml | – month: 06 year: 2019 text: 2019-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | JAMA surgery |
PublicationTitleAlternate | JAMA Surg |
PublicationYear | 2019 |
Publisher | American Medical Association |
Publisher_xml | – name: American Medical Association |
References | 30892658 - JAMA Surg. 2019 Jun 1;154(6):508-509 Hughes (soi190005r4) 1954; 36 Low (soi190005r6) 1986; 15 Norii (soi190005r10) 2015; 78 Scott (soi190005r13) 2013; 75 Morrison (soi190005r9) 2014; 41 Stannard (soi190005r5) 2011; 71 Clarke (soi190005r16) 2002; 52 Tibbits (soi190005r18) 2018; 85 Brenner (soi190005r14) 2013; 75 Brenner (soi190005r15) 2018; 226 Wasicek (soi190005r17) 2018; 84 Rhee (soi190005r1) 2014; 260 Harma (soi190005r11) 2004; 44 Stensballe (soi190005r3) 2016; 22 Pieper (soi190005r19) 2018; 84 soi190005r21 Acosta (soi190005r2) 1998; 186 Avaro (soi190005r12) 2011; 71 Brenner (soi190005r8) 2018; 153 DuBose (soi190005r7) 2016; 81 Brenner (soi190005r20) 2018; 3 Rasmussen (soi190005r22) 2017; 83 soi190005r23 |
References_xml | – volume: 81 start-page: 409 issue: 3 year: 2016 ident: soi190005r7 article-title: The AAST prospective Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery (AORTA) registry: data on contemporary utilization and outcomes of aortic occlusion and resuscitative balloon occlusion of the aorta (REBOA). publication-title: J Trauma Acute Care Surg doi: 10.1097/TA.0000000000001079 contributor: fullname: DuBose – volume: 153 start-page: 130 issue: 2 year: 2018 ident: soi190005r8 article-title: Use of resuscitative endovascular balloon occlusion of the aorta for proximal aortic control in patients with severe hemorrhage and arrest. publication-title: JAMA Surg doi: 10.1001/jamasurg.2017.3549 contributor: fullname: Brenner – volume: 85 start-page: 101 issue: 1 year: 2018 ident: soi190005r18 article-title: Location is everything: the hemodynamic effects of REBOA in zone 1 versus zone 3 of the aorta. publication-title: J Trauma Acute Care Surg doi: 10.1097/TA.0000000000001858 contributor: fullname: Tibbits – volume: 75 start-page: 122 issue: 1 year: 2013 ident: soi190005r13 article-title: A novel fluoroscopy-free, resuscitative endovascular aortic balloon occlusion system in a model of hemorrhagic shock. publication-title: J Trauma Acute Care Surg doi: 10.1097/TA.0b013e3182946746 contributor: fullname: Scott – volume: 260 start-page: 13 issue: 1 year: 2014 ident: soi190005r1 article-title: Increasing trauma deaths in the United States. publication-title: Ann Surg doi: 10.1097/SLA.0000000000000600 contributor: fullname: Rhee – volume: 84 start-page: 971 issue: 6 year: 2018 ident: soi190005r17 article-title: Life over limb: lower extremity ischemia in the setting of resuscitative endovascular balloon occlusion of the aorta (REBOA). publication-title: Am Surg doi: 10.1177/000313481808400650 contributor: fullname: Wasicek – volume: 84 start-page: 449 issue: 3 year: 2018 ident: soi190005r19 article-title: Resuscitative endovascular balloon occlusion of the aorta for pelvic blunt trauma and life-threatening hemorrhage: a 20-year experience in a level I trauma center. publication-title: J Trauma Acute Care Surg doi: 10.1097/TA.0000000000001794 contributor: fullname: Pieper – volume: 71 start-page: 1869 issue: 6 year: 2011 ident: soi190005r5 article-title: Resuscitative endovascular balloon occlusion of the aorta (REBOA) as an adjunct for hemorrhagic shock. publication-title: J Trauma contributor: fullname: Stannard – ident: soi190005r23 – volume: 226 start-page: 730 issue: 5 year: 2018 ident: soi190005r15 article-title: Resuscitative endovascular balloon occlusion of the aorta and resuscitative thoracotomy in select patients with hemorrhagic shock: early results from the American Association for the Surgery of Trauma’s Aortic Occlusion in Resuscitation for Trauma and Acute Care Surgery Registry. publication-title: J Am Coll Surg doi: 10.1016/j.jamcollsurg.2018.01.044 contributor: fullname: Brenner – volume: 3 start-page: e000154 issue: 1 year: 2018 ident: soi190005r20 article-title: Joint statement from the American College of Surgeons Committee on Trauma (ACS COT) and the American College of Emergency Physicians (ACEP) regarding the clinical use of resuscitative endovascular balloon occlusion of the aorta (REBOA). publication-title: Trauma Surg Acute Care Open doi: 10.1136/tsaco-2017-000154 contributor: fullname: Brenner – ident: soi190005r21 – volume: 52 start-page: 420 issue: 3 year: 2002 ident: soi190005r16 article-title: Time to laparotomy for intra-abdominal bleeding from trauma does affect survival for delays up to 90 minutes. publication-title: J Trauma contributor: fullname: Clarke – volume: 22 start-page: 591 issue: 6 year: 2016 ident: soi190005r3 article-title: Haemostatic resuscitation in trauma: the next generation. publication-title: Curr Opin Crit Care doi: 10.1097/MCC.0000000000000359 contributor: fullname: Stensballe – volume: 83 start-page: 732 issue: 4 year: 2017 ident: soi190005r22 article-title: Military-civilian partnership in device innovation: development, commercialization and application of resuscitative endovascular balloon occlusion of the aorta. publication-title: J Trauma Acute Care Surg doi: 10.1097/TA.0000000000001661 contributor: fullname: Rasmussen – volume: 186 start-page: 528 issue: 5 year: 1998 ident: soi190005r2 article-title: Lethal injuries and time to death in a level I trauma center. publication-title: J Am Coll Surg doi: 10.1016/S1072-7515(98)00082-9 contributor: fullname: Acosta – volume: 41 start-page: 130 issue: 2 year: 2014 ident: soi190005r9 article-title: Use of resuscitative endovascular balloon occlusion of the aorta in a highly lethal model of noncompressible torso hemorrhage. publication-title: Shock doi: 10.1097/SHK.0000000000000085 contributor: fullname: Morrison – volume: 78 start-page: 721 issue: 4 year: 2015 ident: soi190005r10 article-title: Survival of severe blunt trauma patients treated with resuscitative endovascular balloon occlusion of the aorta compared with propensity score–adjusted untreated patients. publication-title: J Trauma Acute Care Surg doi: 10.1097/TA.0000000000000578 contributor: fullname: Norii – volume: 36 start-page: 65 issue: 1 year: 1954 ident: soi190005r4 article-title: Use of an intra-aortic balloon catheter tamponade for controlling intra-abdominal hemorrhage in man. publication-title: Surgery contributor: fullname: Hughes – volume: 44 start-page: 170 issue: 2 year: 2004 ident: soi190005r11 article-title: Balloon occlusion of the descending aorta in the treatment of severe post-partum haemorrhage. publication-title: Aust N Z J Obstet Gynaecol doi: 10.1111/ajo.2004.44.issue-2 contributor: fullname: Harma – volume: 15 start-page: 1466 issue: 12 year: 1986 ident: soi190005r6 article-title: Preliminary report on the use of the Percluder occluding aortic balloon in human beings. publication-title: Ann Emerg Med doi: 10.1016/S0196-0644(86)80945-3 contributor: fullname: Low – volume: 71 start-page: 720 issue: 3 year: 2011 ident: soi190005r12 article-title: Forty-minute endovascular aortic occlusion increases survival in an experimental model of uncontrolled hemorrhagic shock caused by abdominal trauma. publication-title: J Trauma doi: 10.1097/TA.0b013e318221a94a contributor: fullname: Avaro – volume: 75 start-page: 506 issue: 3 year: 2013 ident: soi190005r14 article-title: A clinical series of resuscitative endovascular balloon occlusion of the aorta for hemorrhage control and resuscitation. publication-title: J Trauma Acute Care Surg doi: 10.1097/TA.0b013e31829e5416 contributor: fullname: Brenner |
SSID | ssj0000800439 |
Score | 2.681797 |
Snippet | IMPORTANCE: The need for improved methods of hemorrhage control and resuscitation has resulted in a reappraisal of resuscitative endovascular balloon occlusion... The need for improved methods of hemorrhage control and resuscitation has resulted in a reappraisal of resuscitative endovascular balloon occlusion of the... ImportanceThe need for improved methods of hemorrhage control and resuscitation has resulted in a reappraisal of resuscitative endovascular balloon occlusion... This case-control study uses the American College of Surgeons Trauma-Quality Improvement Program data set to evaluate the outcomes in trauma patients after... |
SourceID | pubmedcentral proquest crossref pubmed ama |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 500 |
SubjectTerms | Abdominal Injuries - diagnosis Abdominal Injuries - mortality Abdominal Injuries - surgery Aged Aorta, Abdominal - injuries Aorta, Abdominal - surgery Aorta, Thoracic - injuries Aorta, Thoracic - surgery Balloon Occlusion - methods Endovascular Procedures - methods Female Humans Injury Severity Score Male Middle Aged Online First Original Investigation Propensity Score Resuscitation - methods Retrospective Studies Survival Rate - trends Thoracic Injuries - diagnosis Thoracic Injuries - mortality Thoracic Injuries - surgery Trauma Severity Indices United States - epidemiology |
Title | Nationwide Analysis of Resuscitative Endovascular Balloon Occlusion of the Aorta in Civilian Trauma |
URI | http://dx.doi.org/10.1001/jamasurg.2019.0096 https://www.ncbi.nlm.nih.gov/pubmed/30892574 https://search.proquest.com/docview/2194585886 https://pubmed.ncbi.nlm.nih.gov/PMC6584250 |
Volume | 154 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdb97KXse4zWzs02FtxkW3Zlh63ki6MfrwkEPZiZEmmhsUpi71C__rdyd9tH7pBMMFS5ET3y-lOd_cTIV9EEhilOfdsEmqPg8XhKd9EXhYLoUKtte9jcfL5RbxY8R_raD3kz7vqkio71rcP1pX8j1ThHsgVq2T_QbL9oHAD3oN84QoShuujZNyQWt8U5i65yK6Gla1qOL3npRnyTb9hnB0Efqn1r3rXGouuugTNcFcCWPwp3NYHrGJ1q7Q74xUU9NFuVEftMm8wguBQgnlUfb7GT4uxpCZRuL5Sm40y_WYOJhKUQ_hhyLNdqE1hXHrB-Xb0mXZTAuuguuSpY-uUV-DHwgNnaappG77oFlJjvRkxNlqCI0f1cF-7D6cK4G_FvDwkG5UPUGlfXKanq7OzdDlfL5-SZ8iSiAcrfF_7_QYcmspgjbWFVB0T1XTgMf1uZ7Lc80PuptOO7JPlS_KidSzo1wYl--SJLV8TPSCEdgih25xOEELHCKEtQmiPEOwPCKEOIbQoaYcQ2iDkDVmdzpcnC689VsNTYLxWHvw7M1-zxDAF31kwoWJlM8lyI00Y5EyCEReZWItEJ5EEjW_ygOk8YtoYKVUcviV75ba07wmFFp5bYaxSPveVLxMTJNxwIwS8wnxGXsH8pdcNcUoaJBi2DWfkqJvPvqlhzwZftJVBijJIUQYz8rmb8hRUH8azVGm39S6FxZaDtysE9HnXiKAfL2RCwmrEZySZCKfvgLTq05ayuHL06miTg2Pw4RHP_UieD-g_IHvV79oegpFaZZ8c2P4CyGOagw |
link.rule.ids | 230,314,780,784,885,27924,27925 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nationwide+Analysis+of+Resuscitative+Endovascular+Balloon+Occlusion+of+the+Aorta+in+Civilian+Trauma&rft.jtitle=JAMA+surgery&rft.au=Joseph%2C+Bellal&rft.au=Zeeshan%2C+Muhammad&rft.au=Sakran%2C+Joseph+V&rft.au=Hamidi%2C+Mohammad&rft.date=2019-06-01&rft.eissn=2168-6262&rft.volume=154&rft.issue=6&rft.spage=500&rft.epage=508&rft_id=info:doi/10.1001%2Fjamasurg.2019.0096&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2168-6254&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2168-6254&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2168-6254&client=summon |